Stockreport

CRISPR Therapeutics Pivots Beyond Casgevy, Highlights CTX310 Data and New Cardiovascular Push [Yahoo! Finance]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF roughly in thirds (Casgevy, Phase 1 assets like CTX310/CTX320/CTX611, and deeper pipeline) and prioritizing new franchises in cardiovascular and autoimmune disease with [Read more]